Christine Kwiecinski-Schoolik

Christine Kwiecinski-Schoolik has extensive experience in the medical affairs and oncology sectors, currently serving as a Clinical Trial Liaison at The Medical Affairs Company (TMAC) since September 2022. Previously, Christine held the position of Director of Medical Affairs Strategic Accounts at GSK Oncology from April 2020 to May 2022 and worked as an Associate Director and Medical Science Liaison at Novartis in Solid Tumor Oncology from June 2016 to March 2020. Other roles include Medical Science Liaison for Hematology/Oncology at Jazz Pharmaceuticals and Associate Director of MSL Training and Development at Eisai. Additionally, Christine served as Independent Consultant focusing on clinical trial development and management, MSL training, and scientific writing. Christine began the career in medical science liaison roles at Ligand Pharmaceuticals and Aventis Pharmaceuticals, demonstrating a strong track record in oncology communications and training. Academic credentials include a B.S. in Biology from DeSales University and an MSN in Nursing with a focus on Oncology from Gwynedd Mercy University.